Efficacy of intravenous immunoglobulin in multifocal motor neuropathy

Annals of the New York Academy of Sciences

Volumn 1110, Issue , 2007, Pages 248-255

  Leger, Jean Marc ^a   Vargas, Steven ^a,b   Lievens, Isabelle ^a,c  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^c UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Anti GM1 antibodies; Conduction block; Intravenous immunoglobulins (IVIg); Multifocal motor neuropathy

Indexed keywords

CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; PLACEBO; STEROID;

CLINICAL TRIAL; CONFERENCE PAPER; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG INFUSION; GOLD STANDARD; HUMAN; LONG TERM CARE; MOTOR NEUROPATHY; MUSCLE STRENGTH; PLASMAPHERESIS; PRACTICE GUIDELINE; SCORING SYSTEM; SHORT COURSE THERAPY; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 35748955223     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1423.026     Document Type: Conference Paper

References (37)

1. ROTH, G., J. ROTH, M. MAGISTRIS, et al. 1986. Motor neuropathy with proximal multifocal persistent block, fasciculations and myokymia. Evolution to tetraplegia. Eur. Neurol. 25: 416-423.
2. PESTRONK, A., D.R. CORNBLATH, A.A. ILYAS, et al. 1988. A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Ann. Neurol. 24: 73-78.
3. NOBILE-ORAZIO, E., A. CAPPELLARI & A. PRIORI. 2005. Multifocal motor neuropathy: current concepts and controversies. Muscle Nerve 31: 663-680.
4. LÉGER, J.M. & A. BEHIN. 2005. Multifocal motor neuropathy. Curr. Opin. Neurol. 18: 567-573.
5. LÉGER, J.M. & S. VARGAS. 2006. Neuropathie motrice multifocale avec blocs de conduction persistants. Une neuropathie dysimmunitaire chronique. Presse Med. 35: 720-727.
6. LÉGER, J.M., R. BEAUDET, G. BONNELYE. 2006. Prise en charge des neuropathies motrices multifocales avec blocs de conduction en France en 2005. Résultats d'une enquête nationale d'opinion. Rev. Neurol. 162(Hors-série 1): 3S27-3S46.
7. WORKSHOP REPORT, 79TH ENMC INTERNATIONAL WORKSHOP. 2001. Multifocal motor neuropathy 14-15 April 2000, Hilversum, the Netherlands. Muscle Nerve 11: 309-314.
8. OLNEY, R.K., R.A. LEWIS, T.D. PUTNAM, et al. 2003. Consensus criteria for the diagnosis of multifocal motor neuropathy. Muscle Nerve 27: 117-121.
9. WILLISON, H.J. & N.M. YUKI. 2002. Peripheral neuropathies and anti-glycolipid antibodies. Brain 125: 2591-2625.
10. EUROPEAN FEDERATION OF NEUROLOGICAL SOCIETIES/PERIPHERAL NERVE SOCIETY GUIDELINE ON MANAGEMENT OF MULTIFOCAL MOTOR NEUROPATHY. 2006. Report of a joint task force of the EFNS and the PNS. J. Peripher. Nerv. Syst. 11: 1-8.
11. SAPERSTEIN, D.S., J.S. KATZ, A.A. AMATO, et al. 2001. Clinical spectrum of chronic acquired demyelinating polyneuropathies. Muscle Nerve 24: 311-324.
12. VAN ASSELDONK, J.T., H. FRANSSEN, R.M. VAN DEN BERG-VOS, et al. 2005. Multifocal motor neuropathy. Lancet Neurol. 4: 309-319.
13. GOLD, R., M. STANGEL, M.C. DALAKAS. 2007. Drug insight: the use of intravenous immunoglobulin in neurology-therapeutic considerations and practical issues. Nat. Clin. Pract. Neurol. 3: 36-44.
14. VAN SCHAIK, I.N., M.M. VERMEULEN, R. DE HAAN, et al. 2004. Intravenous immunoglobulin for multifocal motor neuropathy (Cochrane Review). In The Cochrane Library, Issue 3. John Wiley & Sons. Chichester, U.K.
15. UMAPATHI, T., R.A.C. HUGHES, E. NOBILE- ORAZIO, et al. 2002. Immunosuppressive treatments for multifocal motor neuropathy (Cochrane Review). In The Cochrane Library, Issue 2. Update Software Ltd. Oxford.
16. VAN DEN BERG, L.H., H. LOCKHORST, J.H.J. WOKKE. 1997. Pulsed high-dose dexamethasone is not effective in patients with multifocal motor neuropathy. Neurology 48: 1135.
17. CARPO, M., A. CAPPELLARI, G. MORA, et al. 1998. Deterioration of multifocal motor neuropathy after plasma exchange. Neurology 50: 1480-1482.
18. VIALA, K., T. RENIÉ, T. MAISONOBE, et al. 2004. Follow-up and response to treatment in 23 patients with Lewis-Sumner syndrome. Brain 127: 2010-2017.
19. NOBILE-ORAZIO, E., A. CAPELLARI, N. MEUCCI, et al. 2002. Multifocal motor neuropathy: clinical and immunological features and response to IVIg in relation to the presence and degree of motor conduction block. J. Neurol. Neurosurg. Psychiatr. 6: 761-766.
20. AZULAY, J.P., O. BLIN, J. POUGET, et al. 1994. Intravenous immunoglobulin treatment in patients with motor neuron syndromes associated with anti-GM1 antibodies: a double-blind, placebo-controlled study. Neurology 44: 429-432.
21. VAN DEN BERG, L.H., H. KERKHOFF, P.L. OEY, et al. 1995. Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulins: a double-blind, placebo-controlled study. J. Neurol. Neurosurg. Psychiatr. 59: 248-252.
22. FEDERICO, P., D.W. ZOCHODNE, A.F. HAHN, et al. 2000. Multifocal motor neuropathy improved by IVIg. Randomized, double-blind, placebo-controlled study. Neurology 55: 1256-1262.
23. LÉGER, J.M., B. CHASSANDE, L. MUSSET, et al. 2001. Intravenous immunoglobulin therapy in multifocal motor neuropathy. A double-blind, placebo-controlled study. Brain 124: 145-153.
24. VAN DEN BERG-VOS, R.M., H. FRANSSEN, J.H. WOKKE, et al. 2000. Multifocal motor neuropathy: diagnostic criteria that predict the response to immunoglobulin treatment. Ann. Neurol. 41: 919-926.
25. TAYLOR, B.V., R.A. WRIGH, C.M. HARPER, et al. 2000. Natural history of 46 patients with multifocal motor neuropathy with conduction block. Muscle Nerve 23: 900-908.
26. VAN DEN BERG-VOS, R.M., H. FRANSSEN, J.H.J. WOKKE, et al. Multifocal motor neuropathy: long-term clinical and electrophysiological assessment of intravenous immunoglobulin maintenance treatment. Brain 125: 1875-1886.
27. TERENGHI, F., A. CAPPELLARI, A. BERSANO, et al. 2004. How long is IVIg effective in multifocal motor neuropathy? Neurology 62: 666-668.
28. VUCIC, S., K.R. BLACK, P.S. TICK CHONG, et al. 2004. Multifocal motor neuropathy. Decrease in conduction blocks and reinnervation with long-term IVIg. Neurology 63: 1264-1269.
29. LÉGER, J.M., K. VIALA, F. CANCALON, et al. 2005 Are intravenous immunoglobulins a long-term therapy of multifocal motor neuropathy ? A retrospective study of response to IVIg and of its predictive criteria in 40 patients. Neurology 64(Suppl 1): A 412
30. HUGHES, R., CIDP AND MMN TRIAL GROUP. 2005. 129th ENMC International Workshop: clinical trials for chronic inflammatory demyelinating polyradiculoneuropathy and multifocal motor neuropathy. 27th October 2004, Schiphol Airport the Netherlands. Neuromusc. Disord. 15: 321-325.
31. MERKIES, I.S., P.I. SCHMITZ, F.G. VAN DER MÉCHÉ, et al. 2002. Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies. J. Neurol. Neurosurg. Psychiatry 72: 596-601.
32. HOLMAN, R., R. LINDEBOOM, M. VERMEULEN, et al. 2004. AMC Linear Disability Score project in a population requiring residential care: psychometric properties. Health Qual. Life Outcomes 2: 42.
33. LÉGER, J.M. 2005. A review of the medical management of chronic inflammatory demyelinating polyradiculoneuropathy. Expert Opin. Pharmacother. 6: 569-582.
34. DYCK, P.J. & P.C. O'BRIEN. 2006. Polyneuropathy dysfunction scores. J. Neurol. Neurosurg. Psychiatry 77: 899-900.
35. MERKIES, I.S.J. & G. LAURIA. 2006. Workshop report: 131st ENMC International Workshop on selection of outcome measures for peripheral neuropathy clinical trials. 10-12 December 2004, Naarden, the Netherlands. Neuromusc. Disord. 16: 149-156.
36. MERKIES, I.S.J. & P.I.M. SCHMITZ. 2006. Getting closer to patients: the INCAT Overall Disability Sum Score relates better to patients' own clinical judgement in immune-mediated polyneuropathies. J. Neurol. Neurosurg. Psychiatry 77: 970-972.
37. GRAHAM, R.C. & R.A.C. HUGHES. 2006. A modified peripheral neuropathy scale: the Overall Neuropathy Limitations Scale. J. Neurol. Neurosurg. Psychiatry 77: 973-976.